loanDepot, Inc. Form 8-K Summary
Business Context and Reporting Period
loanDepot, Inc. filed a Current Report on Form 8-K dated June 7, 2023, reporting the final voting results from its 2023 Annual Meeting of Stockholders held on June 7, 2023. The filing was signed on June 9, 2023.
Voting Results
| Proposal | For | Against | Withheld/Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Election of Andrew Dodson | 1,217,603,430 | — | 1,672,221 withheld | 16,696,828 |
| Election of Steven Ozonian | 1,214,771,485 | — | 4,504,166 withheld | 16,696,828 |
| Election of Pamela Patenaude | 1,217,645,568 | — | 1,630,083 withheld | 16,696,828 |
| Ratification of Ernst & Young LLP as independent auditor | 1,235,705,214 | 218,485 | 48,780 abstain | 0 |
| Advisory approval of named executive officer compensation | 1,208,359,503 | 10,741,355 | 174,793 abstain | 16,696,828 |
| Second Amendment to 2021 Omnibus Incentive Plan | 1,202,832,396 | 16,348,709 | 94,546 abstain | 16,696,828 |
Material Changes and Financial Metrics
All three nominees—Andrew Dodson, Steven Ozonian, and Pamela Patenaude—were elected to three-year Class II director terms. Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
The advisory vote on named executive officer compensation was approved. Stockholders also approved an amendment to the 2021 Omnibus Incentive Plan authorizing an additional 15,000,000 Class A common shares for issuance.
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating guidance, or other financial metrics.
Outlook, Risks, and Unusual Items
The filing contains no management outlook, risk updates, contingencies, or unusual operating items. The approved increase in shares available under the incentive plan may result in future equity awards and potential dilution, but the filing does not quantify any expected dilution or awards.
Investor Verification Items
- Verify the elected directors’ terms and board committee assignments in subsequent filings.
- Review future disclosures for equity awards issued under the amended incentive plan and their potential dilutive effect.
- Confirm Ernst & Young LLP’s continuing appointment and any audit-related developments.
- Review the company’s periodic reports for financial performance, liquidity, debt, guidance, and operating risks, which are not addressed in this 8-K.